The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be able to administer themselves

Gaithersburg, Maryland-based MedImmune has received the FDA’s approval of its FluMist nasal spray flu vaccine, meaning no physician needed.

FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.

FluMist contains a weakened form of live flu virus strains and is sprayed into the nose. “The nasal spray is a live vaccine so it's only indicated to give to healthy individuals who don't have any immunocompromising condition,” Edler said. FluMist is recommended for anyone between the ages of two and 49.

The FDA has approved a nasal spray flu vaccine for home use. Here's how it works, and when it will be available.

The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered flu vaccine option.

The wait for a flu shot at your doctor's office or pharmacy may soon be a thing of the past. The U.S. Food and Drug Administration has approved FluMist nasal spray as the first influenza vaccine for self-administration at home.

The Food and Drug Administration (FDA) has approved the first-ever influenza vaccine that can be administered at home. It’s a nasal spray vaccine called FluMist, and it’s been